Quadrant Capital Group LLC Ionis Pharmaceuticals Inc Transaction History

Quadrant Capital Group LLC

  • $1.42 Billion
  • Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 870 shares of IONS stock, worth $29,588. This represents 0.0% of its overall portfolio holdings.

Number of Shares
870
Previous 860 1.16%
Holding current value
$29,588
Previous $40,000 15.0%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$40.06 - $51.86 $400 - $518
10 Added 1.16%
870 $34,000
Q2 2024

Aug 12, 2024
BUY
$36.45 - $47.7 $10,424 - $13,642
286 Added 49.83%
860 $40,000
Q1 2024

May 15, 2024
SELL
$42.03 - $53.55 $4,076 - $5,194
-97 Reduced 14.46%
574 $24,000
Q4 2023

Feb 08, 2024
BUY
$43.39 - $51.63 $3,601 - $4,285
83 Added 14.12%
671 $33,000
Q2 2023

Aug 09, 2023
SELL
$34.73 - $43.33 $69 - $86
-2 Reduced 0.34%
588 $24,000
Q1 2023

May 11, 2023
BUY
$33.58 - $41.2 $11,517 - $14,131
343 Added 138.87%
590 $21,000
Q4 2022

Feb 10, 2023
SELL
$37.12 - $46.52 $1,855 - $2,326
-50 Reduced 16.84%
247 $9,000
Q3 2022

Nov 10, 2022
BUY
$36.54 - $48.66 $1,242 - $1,654
34 Added 12.93%
297 $13,000
Q2 2022

Aug 09, 2022
SELL
$31.71 - $43.0 $126 - $172
-4 Reduced 1.5%
263 $10,000
Q1 2022

May 06, 2022
SELL
$29.88 - $37.04 $2,181 - $2,703
-73 Reduced 21.47%
267 $10,000
Q4 2021

Feb 01, 2022
SELL
$25.61 - $35.1 $3,226 - $4,422
-126 Reduced 27.04%
340 $10,000
Q3 2021

Nov 12, 2021
BUY
$33.54 - $40.55 $13,684 - $16,544
408 Added 703.45%
466 $16,000
Q2 2021

Aug 09, 2021
SELL
$34.54 - $47.25 $7,149 - $9,780
-207 Reduced 78.11%
58 $2,000
Q1 2021

May 12, 2021
BUY
$42.51 - $63.78 $425 - $637
10 Added 3.92%
265 $12,000
Q4 2020

Feb 16, 2021
BUY
$45.3 - $60.27 $6,296 - $8,377
139 Added 119.83%
255 $14,000
Q3 2020

Nov 13, 2020
BUY
$47.45 - $62.95 $3,558 - $4,721
75 Added 182.93%
116 $6,000
Q2 2020

Aug 13, 2020
SELL
$46.85 - $61.05 $21,035 - $27,411
-449 Reduced 91.63%
41 $2,000
Q1 2020

May 15, 2020
BUY
$41.6 - $63.4 $19,427 - $29,607
467 Added 2030.43%
490 $23,000
Q4 2019

Feb 03, 2020
SELL
$53.85 - $65.27 $10,500 - $12,727
-195 Reduced 89.45%
23 $1,000
Q3 2019

Oct 24, 2019
BUY
$59.06 - $72.15 $11,516 - $14,069
195 Added 847.83%
218 $12,000
Q2 2019

Jul 24, 2019
SELL
$62.09 - $86.14 $40,544 - $56,249
-653 Reduced 96.6%
23 $1,000
Q1 2019

Apr 29, 2019
BUY
$52.92 - $81.17 $34,556 - $53,004
653 Added 2839.13%
676 $53,000
Q2 2017

Aug 15, 2017
BUY
N/A
23
23 $1,000

Others Institutions Holding IONS

# of Institutions
402
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email